Skip to content

Insider · CIK 0001908268

Matthew McManus

presidentofficer

Files at TECH (BIO-TECHNE Corp). First filing -, latest -.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Aug 15, 2025TECH
BIO-TECHNE Corp
MOption exercise
Common Stock
+2,637$0.00$05,615Aug 19, 2025
Aug 15, 2025TECH
BIO-TECHNE Corp
FTax withholding
Common Stock
-880$53.60$47k4,735Aug 19, 2025
Aug 15, 2025TECH
BIO-TECHNE Corp
MOption exercise
Restricted Stock Unitsderivative
-2,637$0.00$05,275Aug 19, 2025
Aug 15, 2025TECH
BIO-TECHNE Corp
AGrant or award
Performance Restricted Stock Unitsderivative
+19,243$0.00$019,243Aug 19, 2025
Aug 15, 2025TECH
BIO-TECHNE Corp
AGrant or award
Restricted Stock Unitsderivative
+9,622$0.00$09,622Aug 19, 2025
Aug 15, 2025TECH
BIO-TECHNE Corp
AGrant or award
Stock Option (Right to Buy)derivative
+24,614$0.00$024,614Aug 19, 2025
Feb 1, 2025TECH
BIO-TECHNE Corp
MOption exercise
Common Stock
+4,620$0.00$04,620Feb 4, 2025
Feb 1, 2025TECH
BIO-TECHNE Corp
FTax withholding
Common Stock
-1,642$73.55$121k2,978Feb 4, 2025
Feb 1, 2025TECH
BIO-TECHNE Corp
MOption exercise
Restricted Stock Unitsderivative
-4,620$0.00$09,241Feb 4, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Matthew McManus: insider trades and track record | InsiderTell